Atossa Therapeutics Inc. (ATOS) announced Loss for second quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line came in at -$6.05 million, or -$0.05 per share. This compares with -$9.83 million, or -$0.08 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.06 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
Atossa Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$6.05 Mln. vs. -$9.83 Mln. last year.-EPS (Q2): -$0.05 vs. -$0.08 last year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.